New York State Common Retirement Fund’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$538K Sell
38,478
-31,762
-45% -$444K ﹤0.01% 1884
2025
Q1
$955K Sell
70,240
-74,484
-51% -$1.01M ﹤0.01% 1648
2024
Q4
$2.95M Sell
144,724
-5,184
-3% -$106K ﹤0.01% 1281
2024
Q3
$4.37M Sell
149,908
-14,037
-9% -$409K 0.01% 1156
2024
Q2
$3.81M Buy
163,945
+38,170
+30% +$886K 0.01% 1241
2024
Q1
$2.58M Buy
125,775
+1,801
+1% +$37K ﹤0.01% 1373
2023
Q4
$2.66M Sell
123,974
-5,879
-5% -$126K ﹤0.01% 1349
2023
Q3
$2.68M Buy
129,853
+3,954
+3% +$81.6K ﹤0.01% 1340
2023
Q2
$3.72M Sell
125,899
-8,995
-7% -$265K ﹤0.01% 1283
2023
Q1
$3.11M Sell
134,894
-16,060
-11% -$370K ﹤0.01% 1359
2022
Q4
$4.2M Buy
150,954
+6,049
+4% +$168K 0.01% 1259
2022
Q3
$4.45M Buy
144,905
+4,076
+3% +$125K 0.01% 1213
2022
Q2
$4.15M Buy
140,829
+5,988
+4% +$176K 0.01% 1286
2022
Q1
$4.34M Buy
134,841
+54
+0% +$1.74K ﹤0.01% 1344
2021
Q4
$6.01M Sell
134,787
-22,106
-14% -$986K 0.01% 1219
2021
Q3
$7.92M Sell
156,893
-23,368
-13% -$1.18M 0.01% 1110
2021
Q2
$14.1M Buy
180,261
+33,358
+23% +$2.62M 0.01% 835
2021
Q1
$8.39M Buy
146,903
+9,605
+7% +$548K 0.01% 1046
2020
Q4
$11.5M Buy
137,298
+58,198
+74% +$4.87M 0.01% 868
2020
Q3
$2.83M Buy
79,100
+21,500
+37% +$770K ﹤0.01% 1400
2020
Q2
$1.39M Buy
57,600
+14,800
+35% +$358K ﹤0.01% 1706
2020
Q1
$749K Hold
42,800
﹤0.01% 1855
2019
Q4
$746K Sell
42,800
-6,800
-14% -$119K ﹤0.01% 2093
2019
Q3
$760K Hold
49,600
﹤0.01% 2119
2019
Q2
$1.03M Sell
49,600
-8,220
-14% -$171K ﹤0.01% 2004
2019
Q1
$1.34M Buy
57,820
+13,120
+29% +$305K ﹤0.01% 1807
2018
Q4
$924K Buy
44,700
+23,900
+115% +$494K ﹤0.01% 1958
2018
Q3
$452K Hold
20,800
﹤0.01% 2460
2018
Q2
$317K Buy
20,800
+12,000
+136% +$183K ﹤0.01% 2654
2018
Q1
$173K Buy
+8,800
New +$173K ﹤0.01% 2792